Brekiya® (dihydroergotamine mesylate)
for Migraine

Brekiya (dihydroergotamine mesylate) is an ergotamine used for the acute treatment of migraine with or without aura and cluster headaches in adults. It works by activating serotonin (5-HT1D) receptors, causing blood vessels in the brain to constrict and blocking pain signals, which helps stop migraine attacks.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
New Articles Icon New Articles
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Migraine